Literature DB >> 6653636

Family study of genetic and environmental factors determining the protein binding of propranolol.

G Alván, K Bergström, O Borgå, L Iselius, N Pedersen.   

Abstract

The unbound fraction of propranolol was found to vary from 1.9 to 13.2% in 434 plasma samples from members of 132 families. As expected, there was a linear correlation between the ratio of bound/unbound propranolol and the orosomucoid concentration (r = 0.67, P less than 0.001). Albumin concentration did not influence propranolol binding. The unbound fraction was negatively correlated with obesity and alcohol intake, but was not significantly influenced by age and sex. By applying path analysis, 21% of the variability in propranolol binding could be ascribed to genetic factors and 5% to common environmental factors.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6653636     DOI: 10.1007/BF00542107

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  19 in total

1.  Serum glycoproteins in monozygotic and dizygotic twins.

Authors:  W L HEINRICHS; M R SHETLAR
Journal:  Proc Soc Exp Biol Med       Date:  1958-10

2.  Skewness in commingled distributions.

Authors:  C J Maclean; N E Morton; R C Elston; S Yee
Journal:  Biometrics       Date:  1976-09       Impact factor: 2.571

3.  Plasma protein binding of basic drugs. II. Importance of alpha 1-acid glycoprotein for interindividual variation.

Authors:  K M Piafsky; O Borgå
Journal:  Clin Pharmacol Ther       Date:  1977-11       Impact factor: 6.875

4.  Resolution of cultural and biological inheritance by path analysis.

Authors:  D C Rao; N E Morton; S Yee
Journal:  Am J Hum Genet       Date:  1976-05       Impact factor: 11.025

5.  Serum proteins in Finnish twins.

Authors:  H Frey; V Näntö; E Kulonen
Journal:  Acta Genet Stat Med       Date:  1968

6.  Age differences in drug binding by plasma proteins: studies on human foetuses, neonates and adults.

Authors:  M Ehrnebo; S Agurell; B Jalling; L O Boréus
Journal:  Eur J Clin Pharmacol       Date:  1971-09       Impact factor: 2.953

7.  Protein binding of ampicillin. Path analysis of a twin material.

Authors:  L Iselius; M Ehrnebo; L O Boréus; J Lindsten
Journal:  Hereditas       Date:  1978       Impact factor: 3.271

8.  Genetic control of interindividual variations in racemic warfarin binding to plasma and albumin of twins.

Authors:  G Wilding; B Paigen; E S Vesell
Journal:  Clin Pharmacol Ther       Date:  1977-12       Impact factor: 6.875

9.  An automated turbidimetric immunoassay for plasma proteins.

Authors:  K Bergström; A K Lefvert
Journal:  Scand J Clin Lab Invest       Date:  1980       Impact factor: 1.713

10.  Inheritance of human alpha-1-acid glycoprotein (orosomucoid) variants.

Authors:  A M Johnson; K Schmid; C A Alper
Journal:  J Clin Invest       Date:  1969-12       Impact factor: 14.808

View more
  6 in total

Review 1.  Ethnic differences in drug disposition and responsiveness.

Authors:  A J Wood; H H Zhou
Journal:  Clin Pharmacokinet       Date:  1991-05       Impact factor: 6.447

2.  Binding of prazosin and propranolol at variable alpha 1-acid glycoprotein and albumin concentrations.

Authors:  G Sager; R Jaeger; C Little
Journal:  Br J Clin Pharmacol       Date:  1989-02       Impact factor: 4.335

Review 3.  Plasma protein binding of drugs in the elderly.

Authors:  S M Wallace; R K Verbeeck
Journal:  Clin Pharmacokinet       Date:  1987-01       Impact factor: 6.447

4.  Interaction of mixed micelles formed from glycocholic acid and lecithin with the protein binding of various drugs.

Authors:  T W Guentert; S Oie; L Paalzow; B M Frey; R Brandt; L J Aarons; M Rowland
Journal:  Br J Clin Pharmacol       Date:  1987-05       Impact factor: 4.335

5.  Polymorphic 2-hydroxylation of desipramine. A population and family study.

Authors:  M L Dahl; L Iselius; C Alm; J O Svensson; D Lee; I Johansson; M Ingelman-Sundberg; F Sjöqvist
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

6.  Propranolol concentrations in blood serum, seminal plasma and saliva in man after a single oral dose.

Authors:  P Mahajan; E D Grech; R M Pearson; E J Ridgway; P Turner
Journal:  Br J Clin Pharmacol       Date:  1984-12       Impact factor: 4.335

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.